Synthesis and Anti-Tuberculosis Activity of Olivacine and Oxygenated Derivatives

Ulrike Schmidt; Gabriele Theumer; Anne Jäger; Olga Kataeva; Baojie Wan; Scott G. Franzblau; Hans-Joachim Knölker

doi:10.20944/preprints201805.0040.v1

Version 1 : Received: 30 April 2018 / Approved: 2 May 2018 / Online: 2 May 2018 (12:54:38 CEST)
Version 2 : Received: 31 May 2018 / Approved: 1 June 2018 / Online: 1 June 2018 (09:39:56 CEST)

A peer-reviewed article of this Preprint also exists.

Schmidt, U.; Theumer, G.; Jäger, A.; Kataeva, O.; Wan, B.; Franzblau, S.G.; Knölker, H.-J. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Molecules 2018, 23, 1402. Schmidt, U.; Theumer, G.; Jäger, A.; Kataeva, O.; Wan, B.; Franzblau, S.G.; Knölker, H.-J. Synthesis and Activity against Mycobacterium tuberculosis of Olivacine and Oxygenated Derivatives. Molecules 2018, 23, 1402.

Journal reference: Molecules 2018, 23, 1402
DOI: 10.3390/molecules23061402

Abstract

The tetracyclic pyrido[4,3-b]carbazole olivacine and four of its oxygenated derivatives have been synthesized by a late-stage palladium-catalyzed Heck-type cyclization of the pyrrole ring as key step. In a test for inhibition of the growth of Mycobacterium tuberculosis 9-methoxyolivacine showed the most significant anti-TB activity with an MIC₉₀ value of 1.5 μM.

Subject Areas

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Synthesis and Anti-Tuberculosis Activity of Olivacine and Oxygenated Derivatives

Abstract

Subject Areas

Comments (0)